866-997-4948(US-Canada Toll Free)

United States CRISPR And CRISPR-Associated (Cas) Genes Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 122 Pages

Notes:
Sales, means the sales volume of CRISPR And CRISPR-Associated (Cas) Genes
Revenue, means the sales value of CRISPR And CRISPR-Associated (Cas) Genes

This report studies sales (consumption) of CRISPR And CRISPR-Associated (Cas) Genes in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Vector-Based
DNA-Free Cas
Split by applications, this report focuses on sales, market share and growth rate of CRISPR And CRISPR-Associated (Cas) Genes in each application, can be divided into
Genome Engineering
Disease Models
Functional Genomics

Table of Contents

United States CRISPR And CRISPR-Associated (Cas) Genes Market Report 2017
1 CRISPR And CRISPR-Associated (Cas) Genes Overview
1.1 Product Overview and Scope of CRISPR And CRISPR-Associated (Cas) Genes
1.2 Classification of CRISPR And CRISPR-Associated (Cas) Genes
1.2.1 Vector-Based
1.2.2 DNA-Free Cas
1.3 Application of CRISPR And CRISPR-Associated (Cas) Genes
1.3.1 Genome Engineering
1.3.2 Disease Models
1.3.3 Functional Genomics
1.4 United States Market Size Sales (Volume) and Revenue (Value) of CRISPR And CRISPR-Associated (Cas) Genes (2012-2022)
1.4.1 United States CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2012-2022)
1.4.2 United States CRISPR And CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2012-2022)

2 United States CRISPR And CRISPR-Associated (Cas) Genes Competition by Manufacturers
2.1 United States CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States CRISPR And CRISPR-Associated (Cas) Genes Revenue and Share by Manufactures (2015 and 2016)
2.3 United States CRISPR And CRISPR-Associated (Cas) Genes Average Price by Manufactures (2015 and 2016)
2.4 CRISPR And CRISPR-Associated (Cas) Genes Market Competitive Situation and Trends
2.4.1 CRISPR And CRISPR-Associated (Cas) Genes Market Concentration Rate
2.4.2 CRISPR And CRISPR-Associated (Cas) Genes Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States CRISPR And CRISPR-Associated (Cas) Genes Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by States (2012-2017)
3.2 United States CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by States (2012-2017)
3.3 United States CRISPR And CRISPR-Associated (Cas) Genes Price by States (2012-2017)

4 United States CRISPR And CRISPR-Associated (Cas) Genes Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Type (2012-2017)
4.2 United States CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Type (2012-2017)
4.3 United States CRISPR And CRISPR-Associated (Cas) Genes Price by Type (2012-2017)
4.4 United States CRISPR And CRISPR-Associated (Cas) Genes Sales Growth Rate by Type (2012-2017)

5 United States CRISPR And CRISPR-Associated (Cas) Genes Sales (Volume) by Application (2012-2017)
5.1 United States CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Application (2012-2017)
5.2 United States CRISPR And CRISPR-Associated (Cas) Genes Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States CRISPR And CRISPR-Associated (Cas) Genes Manufacturers Profiles/Analysis
6.1 Caribou Biosciences
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 CRISPR And CRISPR-Associated (Cas) Genes Product Type, Application and Specification
6.1.2.1 Vector-Based
6.1.2.2 DNA-Free Cas
6.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Addgene
6.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Type, Application and Specification
6.2.2.1 Vector-Based
6.2.2.2 DNA-Free Cas
6.2.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 CRISPR THERAPEUTICS
6.3.2 CRISPR And CRISPR-Associated (Cas) Genes Product Type, Application and Specification
6.3.2.1 Vector-Based
6.3.2.2 DNA-Free Cas
6.3.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Merck KGaA
6.4.2 CRISPR And CRISPR-Associated (Cas) Genes Product Type, Application and Specification
6.4.2.1 Vector-Based
6.4.2.2 DNA-Free Cas
6.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Mirus Bio LLC
6.5.2 CRISPR And CRISPR-Associated (Cas) Genes Product Type, Application and Specification
6.5.2.1 Vector-Based
6.5.2.2 DNA-Free Cas
6.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Editas Medicine
6.6.2 CRISPR And CRISPR-Associated (Cas) Genes Product Type, Application and Specification
6.6.2.1 Vector-Based
6.6.2.2 DNA-Free Cas
6.6.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Takara Bio USA
6.7.2 CRISPR And CRISPR-Associated (Cas) Genes Product Type, Application and Specification
6.7.2.1 Vector-Based
6.7.2.2 DNA-Free Cas
6.7.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Thermo Fisher Scientific
6.8.2 CRISPR And CRISPR-Associated (Cas) Genes Product Type, Application and Specification
6.8.2.1 Vector-Based
6.8.2.2 DNA-Free Cas
6.8.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Horizon Discovery Group
6.9.2 CRISPR And CRISPR-Associated (Cas) Genes Product Type, Application and Specification
6.9.2.1 Vector-Based
6.9.2.2 DNA-Free Cas
6.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Intellia Therapeutics
6.10.2 CRISPR And CRISPR-Associated (Cas) Genes Product Type, Application and Specification
6.10.2.1 Vector-Based
6.10.2.2 DNA-Free Cas
6.10.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 GE Healthcare Dharmacon

7 CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Cost Analysis
7.1 CRISPR And CRISPR-Associated (Cas) Genes Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of CRISPR And CRISPR-Associated (Cas) Genes

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 CRISPR And CRISPR-Associated (Cas) Genes Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of CRISPR And CRISPR-Associated (Cas) Genes Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2017-2022)
11.1 United States CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue Forecast (2017-2022)
11.2 United States CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Type (2017-2022)
11.3 United States CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Application (2017-2022)
11.4 CRISPR And CRISPR-Associated (Cas) Genes Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *